14-day Premium Trial Subscription Sign Up For FreeGet Free

When Should You SELL Your Stocks? Click to watch.

$193.09 (-1.34%)

Volume: 1.171M

Closed: May 19, 2022

Hollow Logo Score: -2.548

Biogen Inc. Stock Forecast

BUY SELL NASDAQ:BIIB
$193.09 (-1.34%)

Volume: 1.171M

Closed: May 19, 2022

Score Hollow Logo -2.548

Biogen Inc. Stock Forecast NASDAQ:BIIB

Price Target and Analyst Ratings

Historical Ratings

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2022-05-04 16.53% Oppenheimer $240.00 $225.00 Maintains Outperform
2022-05-04 29.99% RBC Capital $244.00 $251.00 Maintains Outperform
2022-05-04 8.76% Barclays $219.00 $210.00 Maintains Equal-Weight
2022-05-04 47.6% Morgan Stanley $283.00 $285.00 Maintains Overweight
2022-04-21 39.83% SVB Leerink $300.00 $270.00 Maintains Outperform
2022-04-18 37.24% Wells Fargo $235.00 $265.00 Upgrades Equal-Weight Overweight
2022-04-12 46.56% Morgan Stanley $330.00 $283.00 Maintains Overweight
2022-04-12 13.42% Barclays $235.00 $219.00 Maintains Equal-Weight
2022-04-08 24.29% Oppenheimer $285.00 $240.00 Maintains Outperform
2022-04-08 35.69% Needham $290.00 $262.00 Maintains Buy
2022-03-28 16.53% B of A Securities $230.00 $225.00 Maintains Neutral
2022-03-08 15.49% Stifel $304.00 $223.00 Downgrades Buy Hold
2022-03-03 28.44% RBC Capital $227.00 $248.00 Upgrades Sector Perform Outperform
2022-02-07 57.96% Canaccord Genuity $335.00 $305.00 Maintains Buy
2022-02-04 70.9% Morgan Stanley $360.00 $330.00 Maintains Overweight
2022-02-04 21.7% Wells Fargo $284.00 $235.00 Maintains Equal-Weight
2022-02-04 50.19% Needham $292.00 $290.00 Maintains Buy
2022-02-04 23.26% BMO Capital $260.00 $238.00 Downgrades Outperform Market Perform
2022-01-24 55.37% SVB Leerink $325.00 $300.00 Maintains Outperform
2022-01-20 26.37% Barclays $280.00 $244.00 Maintains Equal-Weight
2022-01-18 86.44% Morgan Stanley $363.00 $360.00 Maintains Overweight
2022-01-18 39.83% HC Wainwright & Co. $452.00 $270.00 Maintains Buy
2022-01-13 4.61% Guggenheim $290.00 $202.00 Downgrades Buy Neutral
2022-01-12 0.99% Wedbush $249.00 $195.00 Maintains Neutral
2022-01-12 7.2% Mizuho $270.00 $207.00 Maintains Neutral
2022-01-12 51.22% Needham $328.00 $292.00 Maintains Buy
2022-01-12 11.86% Piper Sandler $362.00 $216.00 Downgrades Overweight Neutral
2022-01-11 69.87% Needham $386.00 $328.00 Maintains Buy
2022-01-06 88% Morgan Stanley $440.00 $363.00 Maintains Overweight
2021-12-23 42.42% B of A Securities $295.00 $275.00 Maintains Neutral
2021-12-22 81.26% Oppenheimer $390.00 $350.00 Maintains Outperform
2021-12-21 42.94% JP Morgan $324.00 $276.00 Maintains Neutral
2021-12-21 33.62% Baird $296.00 $258.00 Maintains Neutral
2021-12-20 68.32% SVB Leerink $450.00 $325.00 Maintains Outperform
2021-12-09 29.47% Wells Fargo $250.00 Initiates Coverage On Equal-Weight
2021-12-06 40.35% Goldman Sachs $271.00 Initiates Coverage On Neutral
2021-11-19 43.46% RBC Capital $295.00 $277.00 Maintains Sector Perform
2021-11-19 63.14% BMO Capital $315.00 Initiates Coverage On Outperform
2021-10-26 39.83% Mizuho $300.00 $270.00 Maintains Neutral
2021-10-21 94.21% Cowen & Co. $450.00 $375.00 Maintains Outperform
2021-10-21 127.87% Morgan Stanley $447.00 $440.00 Maintains Overweight
2021-10-21 52.78% RBC Capital $325.00 $295.00 Maintains Sector Perform
2021-10-21 101.98% Oppenheimer $450.00 $390.00 Maintains Outperform
2021-10-21 99.91% Needham $398.00 $386.00 Maintains Buy
2021-10-19 106.12% Needham $400.00 $398.00 Maintains Buy
2021-10-15 78.16% Stifel $430.00 $344.00 Maintains Buy
2021-10-15 69.35% Cantor Fitzgerald $427.00 $327.00 Maintains Neutral
2021-10-12 131.5% Morgan Stanley $455.00 $447.00 Maintains Overweight
2021-10-08 107.16% Jefferies $500.00 $400.00 Maintains Buy
2021-10-08 50.19% Barclays $395.00 $290.00 Maintains Equal-Weight
2021-09-29 68.83% RBC Capital $341.00 $326.00 Maintains Sector Perform
2021-09-23 107.16% Needham $400.00 Initiates Coverage On Buy
2021-09-16 128.91% UBS $475.00 $442.00 Maintains Buy
2021-08-02 55.37% Mizuho $244.00 $300.00 Maintains Neutral
2021-07-27 119.07% Canaccord Genuity $359.00 $423.00 Maintains Buy
2021-07-23 135.64% Morgan Stanley $453.00 $455.00 Maintains Overweight
2021-07-23 76.6% RBC Capital $361.00 $341.00 Maintains Sector Perform
2021-07-16 134.61% Morgan Stanley $455.00 $453.00 Maintains Overweight
2021-06-28 83.33% RBC Capital $400.00 $354.00 Maintains Sector Perform
2021-06-18 133.05% Piper Sandler $384.00 $450.00 Upgrades Neutral Overweight
2021-06-14 125.8% Goldman Sachs $246.00 $436.00 Maintains Neutral
2021-06-14 235.08% Truist Securities $458.00 $647.00 Maintains Buy
2021-06-11 158.95% Bernstein $500.00 Upgrades Market Perform Outperform
2021-06-10 139.78% UBS $463.00 Upgrades Neutral Buy
2021-06-10 146% SVB Leerink $380.00 $475.00 Maintains Outperform
2021-06-08 - William Blair - Upgrades Market Perform Outperform
2021-06-08 107.16% RBC Capital $259.00 $400.00 Maintains Sector Perform
2021-06-08 158.95% Jefferies $450.00 $500.00 Maintains Buy
2021-06-08 104.57% Barclays $265.00 $395.00 Maintains Equal-Weight
2021-06-08 135.64% Morgan Stanley $343.00 $455.00 Maintains Overweight
2021-06-08 127.87% Citigroup $200.00 $440.00 Upgrades Sell Neutral
2021-06-08 97.84% Baird $216.00 $382.00 Upgrades Underperform Neutral
2021-06-08 134.09% HC Wainwright & Co. $305.00 $452.00 Maintains Buy
2021-05-18 68.32% Oppenheimer $300.00 $325.00 Maintains Outperform
2021-04-19 77.64% Morgan Stanley $351.00 $343.00 Maintains Overweight
2021-04-12 26.88% Wedbush $236.00 $245.00 Maintains Neutral
2021-02-17 38.8% Cantor Fitzgerald $278.00 $268.00 Maintains Neutral
2021-02-04 75.05% Credit Suisse $350.00 $338.00 Maintains Outperform
2021-02-04 81.78% Morgan Stanley $352.00 $351.00 Maintains Overweight
2021-02-04 57.96% HC Wainwright & Co. $289.00 $305.00 Maintains Buy
2021-02-04 96.8% SVB Leerink $430.00 $380.00 Maintains Outperform
2021-01-19 82.3% Morgan Stanley $357.00 $352.00 Maintains Overweight
2020-11-19 28.96% RBC Capital $244.00 $249.00 Maintains Sector Perform
2020-11-10 37.24% DZ Bank $265.00 Upgrades Hold Buy
2020-11-09 24.29% B of A Securities $240.00 Downgrades Neutral Underperform
2020-11-09 11.35% Cowen & Co. $215.00 Downgrades Outperform Market Perform
2020-11-09 49.67% HC Wainwright & Co. $318.00 $289.00 Maintains Buy
2020-11-09 -9.37% Atlantic Equities $175.00 Downgrades Neutral Underweight
2020-11-09 97.84% SVB Leerink $402.00 $382.00 Maintains Outperform
2020-11-05 86.44% B of A Securities $230.00 $360.00 Upgrades Underperform Neutral
2020-11-05 77.64% BMO Capital $280.00 $343.00 Maintains Market Perform
2020-11-05 108.19% SVB Leerink $342.00 $402.00 Maintains Outperform
2020-10-28 38.8% UBS $268.00 Initiates Coverage On Neutral
2020-10-27 46.05% Mizuho $316.00 $282.00 Maintains Neutral
2020-10-22 81.26% Credit Suisse $359.00 $350.00 Maintains Outperform
2020-10-22 26.37% Wedbush $281.00 $244.00 Maintains Neutral
2020-10-22 84.89% Morgan Stanley $355.00 $357.00 Maintains Overweight
2020-10-20 37.24% Piper Sandler $270.00 $265.00 Maintains Neutral
2020-10-15 21.7% B of A Securities $255.00 $235.00 Maintains Underperform
2020-10-13 83.85% Morgan Stanley $357.00 $355.00 Maintains Overweight

BIIB Stock Trend

The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $186.69 is broken, it will firstly indicate a stronger fall rate.

Given the current short-term trend, the stock is expected to fall -2.85% during the next 3 months and, with a 90% probability hold a price between $181.37 and $214.39 at the end of this 3-month period.

Data

Date Bottom Mid Top
2022-05-23 $186.58 $203.58 $220.58
2022-05-24 $186.48 $203.47 $220.47
2022-05-25 $186.37 $203.37 $220.36
2022-05-26 $186.26 $203.26 $220.26
2022-05-27 $186.16 $203.15 $220.15
2022-05-31 $186.05 $203.05 $220.04
2022-06-01 $185.95 $202.94 $219.94
2022-06-02 $185.84 $202.84 $219.83
2022-06-03 $185.73 $202.73 $219.73
2022-06-06 $185.63 $202.62 $219.62
2022-06-07 $185.52 $202.52 $219.51
2022-06-08 $185.41 $202.41 $219.41
2022-06-09 $185.31 $202.30 $219.30
2022-06-10 $185.20 $202.20 $219.19
2022-06-13 $185.10 $202.09 $219.09
2022-06-14 $184.99 $201.99 $218.98
2022-06-15 $184.88 $201.88 $218.87
2022-06-16 $184.78 $201.77 $218.77
2022-06-17 $184.67 $201.67 $218.66
2022-06-21 $184.56 $201.56 $218.56
2022-06-22 $184.46 $201.45 $218.45
2022-06-23 $184.35 $201.35 $218.34
2022-06-24 $184.25 $201.24 $218.24
2022-06-27 $184.14 $201.13 $218.13
2022-06-28 $184.03 $201.03 $218.02
2022-06-29 $183.93 $200.92 $217.92
2022-06-30 $183.82 $200.82 $217.81
2022-07-01 $183.71 $200.71 $217.71
2022-07-05 $183.61 $200.60 $217.60
2022-07-06 $183.50 $200.50 $217.49

About Biogen Inc.

Biogen Biogen Inc. discovers, develops, manufactures, and delivers therapies for the treatment of neurodegenerative diseases, hematologic conditions, and autoimmune disorders. It offers TECFIDERA, AVONEX, and PLEGRIDY to treat relapsing forms of multiple sclerosis (MS); TYSABRI to treat relapsing forms of MS and Crohn’s disease; and FAMPYRA to improve walking ability for patients with MS. The company also provides ELOCTATE to treat adults and children ... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!
.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT